title: [Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].
authors.forename: Kouichi
authors.initials: K
authors.lastname: Machida
authors.forename: Daisuke
authors.initials: D
authors.lastname: Kawakami
authors.forename: Masuo
authors.initials: M
authors.lastname: Miki
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D017326:Clinical Trials, Phase III as Topic; D004195:Disease Models, Animal; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D008297:Male; D051379:Mice; D051381:Rats; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors; D013607:Tablets; D013747:Tetrabenazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D013997:Time Factors; D050493:Vesicular Monoamine Transport Proteins / Q000037:antagonists & inhibitors*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D015306:Biogenic Monoamines; D017447:Receptors, Dopamine D1; D013607:Tablets; D050493:Vesicular Monoamine Transport Proteins; D013747:Tetrabenazine